Gastrointestinal Cancer

Cancer is one of the primary public health problems worldwide [ 1 ]. In 2022 it is estimated 19.3 million new cancer cases and 10 million deaths, indicating a significant global burden [ 2 ]. Oncological research is focused in finding new and …

Percutaneous thermal ablation is an important component of the multidisciplinary management of both primary and metastatic sarcomas, providing a minimally invasive alternative or adjunct to surgery and radiation therapy. Although the literature …

The biomarker-oriented chemo-immunotherapy is useful and promising in the development of new anticancer agents, since the responders can be enriched by selecting patients with biomarkers. Compared to colorectal and lung cancers, the development of …

The global incidence of cancer is on the increase. It is expected that cancer will become the most frequent cause of death in most countries worldwide during the twenty-first century [ 1 , 2 ]. Despite advances in early detection and treatment …

As of 2020, esophageal cancer (EC) was reported to rank seventh in incidence and sixth in overall mortality among cancers worldwide [ 1 ]. Esophageal squamous cell carcinoma (ESCC) and adenocarcinoma (EAC) are the two main types with 80% of cases …

Folate-mediated one-carbon metabolism (FOCM) plays an important role in colorectal carcinogenesis. Previous studies have assessed the role of folate-mediated one-carbon metabolism (FOCM)-related gene-diet interaction in the aetiology of colorectal …

Hepatocellular carcinoma (HCC) is one of the most lethal malignancies worldwide [ 1 ]. The majority of HCC develops in patients with underlying liver cirrhosis (LC) which provides the opportunity to closely monitor those patients at risk [ 2 , 3 ].